baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

MEDIGENE AG NA O.N./ DE000A1X3W00 /

2024-08-02 8:16:01 AM	Chg. -0.005	Volume	Bid9:58:00 PM	Ask9:58:00 PM	Market Capitalization	Dividend Y.	P/E Ratio
1.110EUR	-0.45%	0 Turnover: 0.000	-Bid Size: -	-Ask Size: -	27.51 mill.EUR	0.00%	-

GlobeNewswire 06-27 Medigene Presents Efficient 6-Day TCR-T Therapy Production Process with High Stemness

GlobeNewswire 06-24 Medigene Reports Results of Annual General Meeting

GlobeNewswire 06-21 Medigene to Present at the Cell and Gene Therapy In-Depth Focus Summit 2024

GlobeNewswire 06-20 Medigene AG Announces Lead Selection for MDG2021, Expanding TCR-T KRAS Library Targeting Solid Tumor...

GlobeNewswire 06-11 Thermosome Appoints Dr. Sabine Hauck as Chief Technical Officer

GlobeNewswire 05-28 Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology ...

GlobeNewswire 05-21 Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announ...

GlobeNewswire 05-15 Medigene Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS

GlobeNewswire 05-14 Medigene AG Extends Cash Runway into July 2025 After Successful Oversubscribed Capital Raise

GlobeNewswire 05-07 Medigene to Present at Upcoming Conferences

GlobeNewswire 05-06 The Benchmark Company Announces Upcoming Healthcare House Call VIRTUAL One-on-One Investor Conferenc...

GlobeNewswire 05-02 Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1 – targeted T Cell R...

GlobeNewswire 05-02 Medigene Presents Superior TCR-T Cell Functionality by Inclusion of a Costimulatory Switch Protein

GlobeNewswire 04-26 Medigene AG reports Financial Results and Business Update for Q1 2024

GlobeNewswire 04-25 Medigene presents streamlined 6-day, high stemness TCR-T therapy production process

GlobeNewswire 04-17 Medigene to Present at Upcoming Scientific Conferences

GlobeNewswire 04-08 Medigene Presents Favorable Safety Profile of TCR-T Cells with Costimulatory Switch Protein at AACR ...

GlobeNewswire 04-04 Medigene AG Secures European Patent for its iM-TCR Technology

GlobeNewswire 03-28 Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire 03-19 Medigene AG to participate in the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference

GlobeNewswire 03-18 Medigene AG to report full year 2023 financial results on March 28, 2024

GlobeNewswire 03-06 Medigene to Present Favorable Safety Profile of TCR-T Cells upon Addition of Costimulatory Switch Pr...

GlobeNewswire 03-04 Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology to Directly Control TCR-T Safety...

GlobeNewswire 02-29 Medigene Presents at CAR-TCR Summit Europe Showcasing Unique Approach for Development of Differentia...

GlobeNewswire 02-19 Medigene to Present at Upcoming Conferences

MEDIGENE AG NA O.N./ DE000A1X3W00 /

If you wish to receive reply to your feedback, please provide your email address.